Japan Drug Imports Exceeds ¥1 Trillion, Trade Deficit at ¥700 Billion
This article was originally published in PharmAsia News
Executive Summary
Japan's trade data for 2007, released by the Department of Treasury, shows that the country's import of drugs increased by 8.8 percent to ¥1.078 trillion. EU was the biggest exporter, sending ¥634.4 billion worth of drugs to Japan and followed by the U.S., ¥168.3 billion. Import from China jumped 33.1 percent to ¥46.9 billion. Japan exported ¥374.4 billion worth of drugs in 2007, a 0.6 percent increase. The biggest importer of Japanese drugs was the U.S., with a total of ¥127 billion, and followed by EU, ¥119 billion. Japan's export to China was ¥22.7 billion. (Click here for more - Japanese language
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.